top of page

About Us

At Clinika Research, we are driven by a passion for discovery and a dedication to researching innovative products and technologies in the field of alternative health. We strive to transform patient care through dynamic, ethical, and rigorous scientific practices.

WHAT SETS US APART

Patient-Focused Research
We prioritize a patient-centric approach, actively integrating patient perspectives and safety into the research process.

 

Evidence-Based Practices

We are committed to evidence-based research methodologies, ensuring the reliability and credibility of its study findings.

 

Dedicated Alternative Health Expertise

We specialize in the alternative health sector, showcasing a focused understanding of the unique challenges, trends, and opportunities within this specific domain.

 

Comprehensive Services

We offer end-to-end services covering the entire research and development lifecycle.

Strategic Regulatory Guidance

We use our significant expertise in regulatory matters for alternative health products to guide sponsors through the complex landscape; accelerating approvals from regulatory bodies.

 

Agility in Trial Designs

Our agility in implementing adaptive clinical trials demonstrates a proactive stance in optimizing protocols based on real-time data insights.

 

Serving as an Ally to Sponsors

Operating as a trusted ally ensures that sponsors receive unparalleled support and collaboration, enhancing the overall success of their research initiatives.

WHO WE WORK WITH

Pharmaceutical+ Biotech
Companies

Medical
Device
Companies

Startups +
Emerging Companies

Investors +
Funding
Entities

Alternative
Medicine
Companies

Universities +
Governmental
Agencies

Leadership Team

MatthewWiener.png
Matthew Wiener PharmD
CEO

Dr. Matthew Wiener has over 35 years of experience as a clinical research pharmacist. He has been a faculty member at Columbia College of Pharmaceutical Sciences, the University of Colorado, and National Jewish Health; additionally, he directed a private practice research center. Dr. Wiener began his career in oncology, which led him to found Pharmatech, a CRO focused on oncology trials. Under his leadership, Pharmatech pioneered the concept of Just-In-Time clinical trials, significantly reducing the time to start trials and becoming a leader in the field. In 2019, Pharmatech was acquired by Caris Lifesciences, and in 2021, Dr. Wiener founded Clinika Research. He is well-published and a noted speaker on clinical product development and managed care research. Dr. Wiener holds a Doctorate in Pharmacy from Columbia College and a BS in Pharmacy from Brooklyn College of Pharmacy.

JoannaZeiger.png
Joanna Zeiger MS, PhD
CSO
HaliBroncucia.png
Hali Broncucia MAEd
COO
C-watermark_edited_edited_edited.png

Dr. Joanna Zeiger is a renowned cannabis epidemiologist and the Founder and CEO of Canna Research Foundation, a non-profit that focuses on the epidemiological aspects of medical cannabis use. She is the epidemiologist and biostatistician for Clinika Research. Dr. Zeiger has published prolifically in peer-reviewed journals and speaks at conferences and community events. She serves on the Governing Board for the Institute of Cannabis Research at CSU Pueblo. From 1998 to 2010, Dr. Zeiger was a professional athlete, competing in triathlons at an international level, including a 4th place finish at the 2000 Sydney Olympics and a world record win at the 2008 Ironman 70.3 World Championships. Her book, The Champion Mindset: An Athlete’s Guide to Mental Toughness, was published in 2017. Dr. Zeiger holds a BA from Brown University, an MS from Northwestern University, and a PhD from the Johns Hopkins Bloomberg School of Public Health.

Hali Broncucia, MAEd, has devoted over 15 years to research in endocrinology and Type 1 Diabetes, primarily through observational and clinical trials. She has managed more than 10 clinical trials as the research manager at the Barbara Davis Center for Diabetes, focusing on interventions to delay or prevent Type 1 Diabetes. In 2022, Ms. Broncucia joined Clinika Research as the Chief Operations Officer, aiming to enhance support to sponsors, CROs, and clinical sites with her expertise. She earned her BA in Integrative Physiology from the University of Colorado and a Master of Arts in Secondary Science Education from the University of Phoenix.

bottom of page